Current and historical gross, operating and net profit margin for Novo Nordisk (NVO) over the last 10 years. The current net profit margin for Novo Nordisk as of June 30, 2018 is 35.95%.
|Novo Nordisk Annual Profit Margin Summary
|Novo Nordisk Quarterly Profit Margin Summary
||Large Cap Pharmaceutical
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.